Research output per year
Research output per year
Project Details
Description
The BSRBR-RA tracks the progress of people with rheumatoid arthritis (RA) who have been prescribed biologic (including biosimilar) drugs in the UK to monitor the long-term safety of these drugs.
We are proud to be one of the largest prospective studies of patients receiving these drugs in the world with over 20,000 patients registered in the study since it started in 2001.
We are proud to be one of the largest prospective studies of patients receiving these drugs in the world with over 20,000 patients registered in the study since it started in 2001.
| Status | Not started |
|---|
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
-
Association between body weight and tocilizumab effectiveness in rheumatoid arthritis: results from the BSRBR-RA
BSRBR-RA Contributors Group, Tsoi, M. F., Kearsley-Fleet, L., Azadbakht, N., Watson, K., Hyrich, K. L. & Bluett, J., 14 Sept 2024, (E-pub ahead of print) In: Rheumatology (Oxford, England). keae500.Research output: Contribution to journal › Article › peer-review
Open Access -
Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot' study)
Aymon, R., Mongin, D., Bergstra, S. A., Choquette, D., Codreanu, C., De Cock, D., Dreyer, L., Elkayam, O., Huschek, D., Hyrich, K. L., Iannone, F., Inanc, N., Kearsley-Fleet, L., Koca, S. S., Kvien, T. K., Leeb, B. F., Lukina, G., Nordström, D. C., Pavelka, K. & Pombo-Suarez, M. & 9 others, , 12 Mar 2024, In: Annals of the rheumatic diseases. 83, 4, p. 421-428 8 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Potential impact of European Medicines Agency measures to minimise risk of serious side effects on JAKi prescribing and utilisation in the UK
Tian, Z., Kearsley-Fleet, L., Galloway, J., Watson, K., Lunt, M., BSRBR-RA Contributors Group & Hyrich, K. L., 15 May 2024, In: Rheumatology. keae279.Research output: Contribution to journal › Article › peer-review
Open Access